MicroRNAs regulate mitochondrial apoptotic pathway in myocardial ischemia-reperfusion-injury

Biomedicine and Pharmacotherapy

Volumn 84, Issue , 2016, Pages 1635-1644

  Makhdoumi, Pouran ^a   Roohbakhsh, Ali ^a,b   Karimi, Gholamreza ^a,b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Heart; Ischemia reperfusion; MicroRNA; Mitochondria

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 133; MICRORNA 15B; MICRORNA 21; MICRORNA 214; MICRORNA 22; MICRORNA 24; MICRORNA 29; MICRORNA 320; MICRORNA 494; MICRORNA 499; UNCLASSIFIED DRUG;

APOPTOSIS; CELL FUNCTION; CELL SURVIVAL; HEART MITOCHONDRION; HUMAN; MOLECULAR PATHOLOGY; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; BIOLOGICAL MODEL; GENETICS; METABOLISM; MITOCHONDRION; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; HUMANS; MICRORNAS; MITOCHONDRIA; MODELS, BIOLOGICAL; MYOCARDIAL REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 85001073382     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.10.073     Document Type: Review

References (143)

1. [1] Srinivasan, H., Das, S., Mitochondrial miRNA (MitomiR): a new player in cardiovascular health 1. Can. J. Physiol. Pharmacol. 93:10 (2015), 855–861.
2. [2] Ambros, V., The functions of animal microRNAs. Nature 431:7006 (2004), 350–355.
3. [3] Barte, D.P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:2 (2004), 281–297.
4. [4] Xu, P., Vernooy, S.Y., Guo, M., Hay, B.A., The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr. Biol. 13:9 (2003), 790–795.
5. [5] Kwon, C., Han, Z., Olson, E.N., Srivastava, D., MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling. Proc. Natl. Acad. Sci. U. S. A. 102:52 (2005), 18986–18991.
6. [6] Silber, J., Lim, D.A., Petritsch, C., Persson, A.I., Maunakea, A.K., Yu, M., Vandenberg, S.R., Ginzinger, D.G., James, C.D., Costello, J.F., miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med., 6(1), 2008, 14.
7. [7] Tay, Y.M.S., Tam, W.L., Ang, Y.S., Gaughwin, P.M., Yang, H., Wang, W., Liu, R., George, J., Ng, H.H., Perera, R.J., MicroRNA-134 modulates the differentiation of mouse embryonic stem cells, where it causes post-transcriptional attenuation of Nanog and LRH1. Stem Cells 26:1 (2008), 17–29.
8. [8] Chan, J.A., Krichevsky, A.M., Kosik, K.S., MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65:14 (2005), 6029–6033.
9. [9] Xu, C., Lu, Y., Pan, Z., Chu, W., Luo, X., Lin, H., Xiao, J., Shan, H., Wang, Z., Yang, B., The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J. Cell Sci. 120:17 (2007), 3045–3052.
10. [10] Chen, J.-F., Mandel, E.M., Thomson, J.M., Wu, Q., Callis, T.E., Hammond, S.M., Conlon, F.L., Wang, D.-Z., The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38:2 (2006), 228–233.
11. [11] Rao, P.K., Kumar, R.M., Farkhondeh, M., Baskerville, S., Lodish, H.F., Myogenic factors that regulate expression of muscle-specific microRNAs. Proc. Natl. Acad. Sci. 103:23 (2006), 8721–8726.
12. [12] Zhao, Y., Ransom, J.F., Li, A., Vedantham, V., von Drehle, M., Muth, A.N., Tsuchihashi, T., McManus, M.T., Schwartz, R.J., Srivastava, D., Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129:2 (2007), 303–317.
13. [13] Ji, R., Cheng, Y., Yue, J., Yang, J., Liu, X., Chen, H., Dean, D.B., Zhang, C., MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ. Res. 100:11 (2007), 1579–1588.
14. [14] Chang, T.-C., Yu, D., Lee, Y.-S., Wentzel, E.A., Arking, D.E., West, K.M., Dang, C.V., Thomas-Tikhonenko, A., Mendell, J.T., Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 40:1 (2008), 43–50.
15. [15] Macheda, M.L., Rogers, S., Best, J.D., Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J. Cell. Physiol. 202:3 (2005), 654–662.
16. [16] Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., Tuschl, T., Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12:9 (2002), 735–739.
17. [17] Van Rooij, E., Marshall, W.S., Olson, E.N., Toward MicroRNA–based therapeutics for heart disease the sense in antisense. Circ. Res. 103:9 (2008), 919–928.
18. [18] Abdellatif, M., Differential expression of microRNAs in different disease states. Circ. Res. 110:4 (2012), 638–650.
19. [19] Frangogiannis, N.G., Entman, M.L., Chemokines in myocardial ischemia. Trends Cardiovasc. Med. 15:5 (2005), 163–169.
20. [20] Camara, A., Bienengraeber, M., Stowe, D.F., Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury. Front. Physiol., 2(13), 2011 10.3389.
21. [21] Stowe, D.F., Camara, A.K., Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxid. Redox Signal. 11:6 (2009), 1373–1414.
22. [22] Camara, A.K., Lesnefsky, E.J., Stowe, D.F., Potential therapeutic benefits of strategies directed to mitochondria. Antioxid. Redox Signal. 13:3 (2010), 279–347.
23. [23] Koopman, W.J., Nijtmans, L.G., Dieteren, C.E., Roestenberg, P., Valsecchi, F., Smeitink, J.A., Willems, P.H., Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation. Antioxid. Redox Signal. 12:12 (2010), 1431–1470.
24. [24] Ashrafian, H., Frenneaux, M.P., Opie, L.H., Metabolic mechanisms in heart failure. Circulation 116:4 (2007), 434–448.
25. [25] Marín-García, J., Goldenthal, M.J., The mitochondrial organelle and the heart. Revista Española de Cardiología 55:12 (2002), 1293–1310.
26. [26] Pagidipati, N.J., Gaziano, T.A., Estimating deaths from cardiovascular disease: a review of global methodologies of mortality measurement. Circulation 127:6 (2013), 749–756.
27. [27] Oram, J.F., Bennetch, S.L., Neely, J.R., Regulation of fatty acid utilization in isolated perfused rat hearts. J. Biol. Chem. 248:15 (1973), 5299–5309.
28. [28] Wallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., Eppenberger, H., Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the'phosphocreatine circuit'for cellular energy homeostasis. Biochem. J, 281(Pt. 1), 1992, 21.
29. [29] Whitmer, J.T., Idell-Wenger, J.A., Rovetto, M.J., Neely, J.R., Control of fatty acid metabolism in ischemic and hypoxic hearts. J. Biol. Chem. 253:12 (1978), 4305–4309.
30. [30] Whelan, R.S., Kaplinskiy, V., Kitsis, R.N., Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu. Rev. Physiol. 72 (2010), 19–44.
31. [31] Baines, C.P., The mitochondrial permeability transition pore and ischemia-reperfusion injury. Basic Res. Cardiol. 104:2 (2009), 181–188.
32. [32] Marín-García, J., Goldenthal, M.J., Mitochondrial centrality in heart failure. Heart Fail. Rev. 13:2 (2008), 137–150.
33. [33] Shlafer, M., Gallagher, K., Adkins, S., Hydrogen peroxide generation by mitochondria isolated from regionally ischemic and nonischemic dog myocardium. Basic Res. Cardiol. 85:4 (1990), 318–329.
34. [34] Ambrosio, G., Flaherty, J.T., Effects of the superoxide radical scavenger superoxide dismutase, and of the hydroxyl radical scavenger mannitol, on reperfusion injury in isolated rabbit hearts. Cardiovasc. Drugs Ther. 6:6 (1992), 623–632.
35. [35] Toleikis, A., Dž, P., Praškevičius, A., Jasaitis, A., Mitochondrial functions in ischemic myocardium I. Proton electrochemical gradient, inner membrane permeability, calcium transport and oxidative phosphorylation in isolated mitochondria. J. Mol. Cell. Cardiol. 11:1 (1979), 57–76.
36. [36] Forini, F., Nicolini, G., Iervasi, G., Mitochondria as key targets of cardioprotection in cardiac ischemic disease: role of thyroid hormone triiodothyronine. Int. J. Mol. Sci. 16:3 (2015), 6312–6336.
37. [37] Kristen, A.V., Ackermann, K., Buss, S., Lehmann, L., Schnabel, P.A., Haunstetter, A., Katus, H.A., Hardt, S.E., Inhibition of apoptosis by the intrinsic but not the extrinsic apoptotic pathway in myocardial ischemia-reperfusion. Cardiovasc. Pathol. 22:4 (2013), 280–286.
38. [38] Yang, B., Lin, H., Xiao, J., Lu, Y., Luo, X., Li, B., Zhang, Y., Xu, C., Bai, Y., Wang, H., The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat. Med. 13:4 (2007), 486–491.
39. [39] Tang, Y., Zheng, J., Sun, Y., Wu, Z., Liu, Z., Huang, G., MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int. Heart J. 50:3 (2009), 377–387.
40. [40] Boštjančič, E., Zidar, N., Štajer, D., Glavač, D., MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology 115:3 (2009), 163–169.
41. [41] Zhao, Y., Samal, E., Srivastava, D., Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436:7048 (2005), 214–220.
42. [42] Sweetman, D., Goljanek, K., Rathjen, T., Oustanina, S., Braun, T., Dalmay, T., Münsterberg, A., Specific requirements of MRFs for the expression of muscle specific microRNAs, miR-1, miR-206 and miR-133. Dev. Biol. 321:2 (2008), 491–499.
43. [43] Townley-Tilson, W.D., Callis, T.E., Wang, D., MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease. Int. J. Biochem. Cell Biol. 42:8 (2010), 1252–1255.
44. [44] Latchman, D.S., Heat shock proteins and cardiac protection. Cardiovasc. Res. 51:4 (2001), 637–646.
45. [45] Gidlöf, O., Andersson, P., Van Der Pals, J., Götberg, M., Erlinge, D., Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology 118:4 (2011), 217–226.
46. [46] D'Alessandra, Y., Devanna, P., Limana, F., Straino, S., Di Carlo, A., Brambilla, P.G., Rubino, M., Carena, M.C., Spazzafumo, L., De Simone, M., Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur. Heart J. 31:22 (2010), 2765–2773.
47. [47] He, B., Xiao, J., Ren, A.-J., Zhang, Y.-F., Zhang, H., Chen, M., Xie, B., Gao, X.-G., Wang, Y.-W., Role of miR-1 and miR-133a in myocardial ischemic postconditioning. J. Biomed. Sci., 18(1), 2011, 22.
48. [48] Kang, B., Hong, J., Xiao, J., Zhu, X., Ni, X., Zhang, Y., He, B., Wang, Z., Involvement of miR-1 in the protective effect of hydrogen sulfide against cardiomyocyte apoptosis induced by ischemia/reperfusion. Mol. Biol. Rep. 41:10 (2014), 6845–6853.
49. [49] Pan, Z., Sun, X., Ren, J., Li, X., Gao, X., Lu, C., Zhang, Y., Sun, H., Wang, Y., Wang, H., miR-1 exacerbates cardiac ischemia-reperfusion injury in mouse models. PLoS One, 7(11), 2012, e50515.
50. [50] Chen, C.-H., Budas, G.R., Churchill, E.N., Disatnik, M.-H., Hurley, T.D., Mochly-Rosen, D., Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321:5895 (2008), 1493–1495.
51. [51] Mourad, O., Stuchlik, O., Safia, O., Johnson, J.A., Cytochrome c oxidase subunit IV as a marker of protein kinase Cε function in neonatal cardiac myocytes: implications for cytochrome c oxidase activity. Biochem. J 382:3 (2004), 923–932.
52. [52] Zhai, C., Tang, G., Peng, L., Hu, H., Qian, G., Wang, S., Yao, J., Zhang, X., Fang, Y., Yang, S., Inhibition of microRNA-1 attenuates hypoxia/re-oxygenation-induced apoptosis of cardiomyocytes by directly targeting Bcl-2 but not GADD45Beta. Am. J. Transl. Res., 7(10), 2015, 1952.
53. [53] Zhu, H., Fan, G.-C., Role of microRNAs in the reperfused myocardium towards post-infarct remodelling. Cardiovasc. Res. 94:2 (2012), 284–292.
54. [54] Kannan, K., Jain, S.K., Oxidative stress and apoptosis. Pathophysiology 7:3 (2000), 153–163.
55. [55] Hullinger, T.G., Montgomery, R.L., Seto, A.G., Dickinson, B.A., Semus, H.M., Lynch, J.M., Dalby, C.M., Robinson, K., Stack, C., Latimer, P.A., Inhibition of miR-15 protects against cardiac ischemic injury. Circ. Res. 110:1 (2012), 71–81.
56. [56] Nishi, H., Ono, K., Iwanaga, Y., Horie, T., Nagao, K., Takemura, G., Kinoshita, M., Kuwabara, Y., Mori, R.T., Hasegawa, K., MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes. J. Biol. Chem. 285:7 (2010), 4920–4930.
57. [57] Tomasetti, M., Neuzil, J., Dong, L., MicroRNAs as regulators of mitochondrial function: role in cancer suppression. Biochim. Biophys. Acta 1840:4 (2014), 1441–1453.
58. [58] Papagiannakopoulos, T., Shapiro, A., Kosik, K.S., MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res. 68:19 (2008), 8164–8172.
59. [59] Sayed, D., He, M., Hong, C., Gao, S., Rane, S., Yang, Z., Abdellatif, M., MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J. Biol. Chem. 285:26 (2010), 20281–20290.
60. [60] Dong, S., Cheng, Y., Yang, J., Li, J., Liu, X., Wang, X., Wang, D., Krall, T.J., Delphin, E.S., Zhang, C., MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J. Biol. Chem. 284:43 (2009), 29514–29525.
61. [61] Yin, C., Salloum, F.N., Kukreja, R.C., A novel role of microRNA in late preconditioning upregulation of endothelial nitric oxide synthase and heat shock protein 70. Circ. Res. 104:5 (2009), 572–575.
62. [62] Keyes, K.T., Xu, J., Long, B., Zhang, C., Hu, Z., Ye, Y., Pharmacological inhibition of PTEN limits myocardial infarct size and improves left ventricular function postinfarction. Am. J. Physiol. Heart Circ. Physiol. 298:4 (2010), H1198–H1208.
63. [63] Mocanu, M., Yellon, D., PTEN, the Achilles’ heel of myocardial ischaemia/reperfusion injury?. Br. J. Pharmacol. 150:7 (2007), 833–838.
64. [64] Qin, Y., Yu, Y., Dong, H., Bian, X., Guo, X., Dong, S., MicroRNA 21 inhibits left ventricular remodeling in the early phase of rat model with ischemia-reperfusion injury by suppressing cell apoptosis. Int. J. Med. Sci., 9(6), 2012, 413.
65. [65] Si, M., Zhu, S., Wu, H., Lu, Z., Wu, F., Mo, Y., miR-21-mediated tumor growth. Oncogene 26:19 (2007), 2799–2803.
66. [66] Yin, C., Wang, X., Kukreja, R.C., Endogenous microRNAs induced by heat-shock reduce myocardial infarction following ischemia–reperfusion in mice. FEBS Lett. 582:30 (2008), 4137–4142.
67. [67] Moens, A.L., Champion, H.C., Claeys, M.J., Tavazzi, B., Kaminski, P.M., Wolin, M.S., Borgonjon, D.J., Van Nassauw, L., Haile, A., Zviman, M., High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury. Circulation 117:14 (2008), 1810–1819.
68. [68] Sack, M.N., Murphy, E., Schulz, R., The regulation and control of mitochondrial homeostasis in changing cardiac tolerance to ischemia-reperfusion injury: a focused issue. Basic Res. Cardiol. 104:2 (2009), 111–112.
69. [69] Christodoulou, F., Raible, F., Tomer, R., Simakov, O., Trachana, K., Klaus, S., Snyman, H., Hannon, G.J., Bork, P., Arendt, D., Ancient animal microRNAs and the evolution of tissue identity. Nature 463:7284 (2010), 1084–1088.
70. [70] Hu, Y., Matkovich, S.J., Hecker, P.A., Zhang, Y., Edwards, J.R., Dorn, G.W., Epitranscriptional orchestration of genetic reprogramming is an emergent property of stress-regulated cardiac microRNAs. Proc. Natl. Acad. Sci. 109:48 (2012), 19864–19869.
71. [71] Huang, Z.-P., Chen, J., Seok, H.Y., Zhang, Z., Kataoka, M., Hu, X., Wang, D.-Z., MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ. Res. 112:9 (2013), 1234–1243.
72. [72] Gurha, P., Abreu-Goodger, C., Wang, T., Ramirez, M.O., Drumond, A.L., Van Dongen, S., Chen, Y., Bartonicek, N., Enright, A.J., Lee, B., Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction. Circulation 125:22 (2012), 2751–2761.
73. [73] Jazbutyte, V., Fiedler, J., Kneitz, S., Galuppo, P., Just, A., Holzmann, A., Bauersachs, J., Thum, T., MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart. Age 35:3 (2013), 747–762.
74. [74] Goren, Y., Kushnir, M., Zafrir, B., Tabak, S., Lewis, B.S., Amir, O., Serum levels of microRNAs in patients with heart failure. Eur. J. Heart Fail. 14:2 (2012), 147–154.
75. [75] Lesnefsky, E.J., Moghaddas, S., Tandler, B., Kerner, J., Hoppel, C.L., Mitochondrial dysfunction in cardiac disease: ischemia-reperfusion, aging, and heart failure. J. Mol. Cell. Cardiol. 33:6 (2001), 1065–1089.
76. [76] Wang, L., Tang, Z.-P., Zhao, W., Cong, B.-H., Lu, J.-Q., Tang, X.-L., Li, X.-H., Zhu, X.-Y., Ni, X., MiR-22/Sp-1 links estrogens with the up-regulation of cystathionine γ-lyase in myocardium, which contributes to estrogenic cardioprotection against oxidative stress. Endocrinology 156:6 (2015), 2124–2137.
77. [77] Li, Y., Liu, X., Rong, F., PUMA mediates the apoptotic signal of hypoxia/reoxygenation in cardiomyocytes through mitochondrial pathway. Shock 35:6 (2011), 579–584.
78. [78] Forini, F., Kusmic, C., Nicolini, G., Mariani, L., Zucchi, R., Matteucci, M., Iervasi, G., Pitto, L., Triiodothyronine prevents cardiac ischemia/reperfusion mitochondrial impairment and cell loss by regulating miR30a/p53 axis. Endocrinology 155:11 (2014), 4581–4590.
79. [79] Lin, J., Huo, R., Xiao, L., Zhu, X., Xie, J., Sun, S., He, Y., Zhang, J., Sun, Y., Zhou, Z., A novel p53/microRNA-22/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis. Arthritis Rheumatol. 66:1 (2014), 49–59.
80. [80] Du, J.-K., Cong, B.-H., Yu, Q., Wang, H., Wang, L., Wang, C.-N., Tang, X.-L., Lu, J.-Q., Zhu, X.-Y., Ni, X., Upregulation of microRNA-22 contributes to myocardial ischemia-reperfusion injury by interfering with the mitochondrial function. Free Radic. Biol. Med. 96 (2016), 406–417.
81. [81] Vurusaner, B., Poli, G., Basaga, H., Tumor suppressor genes and ROS: complex networks of interactions. Free Radic. Biol. Med. 52:1 (2012), 7–18.
82. [82] Yang, J., Chen, L., Yang, J., Ding, J., Li, S., Wu, H., Zhang, J., Fan, Z., Dong, W., Li, X., MicroRNA-22 targeting CBP protects against myocardial ischemia?reperfusion injury through anti-apoptosis in rats. Mol. Biol. Rep. 41:1 (2014), 555–561.
83. [83] Chen, Z., Qi, Y., Gao, C., Cardiac myocyte-protective effect of microRNA-22 during ischemia and reperfusion through disrupting the caveolin-3/eNOS signaling. Int. J. Clin. Exp. Pathol., 8(5), 2015, 4614.
84. [84] Ait-Si-Ali, S., Ramirez, S., Barre, F.-X., Dkhissi, F., Magnaghi-Jaulin, L., Girault, J., Robin, P., Knibiehler, M., Pritchard, L., Ducommun, B., Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature 396:6707 (1998), 184–186.
85. [85] McManus, K.J., Hendzel, M.J., a transcriptional coactivator and acetyltransferase. Biochem. Cell Biol. 79:3 (2001), 253–266.
86. [86] Avantaggiati, M.L., Ogryzko, V., Gardner, K., Giordano, A., Levine, A.S., Kelly, K., Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89:7 (1997), 1175–1184.
87. [87] Lin, C., Tseng, H., Chen, W., Su, M., Fang, K., Chen, R., Wu, M., Intracellular zinc release-activated ERK-dependent GSK-3β-p53 and Noxa-Mcl-1 signaling are both involved in cardiac ischemic-reperfusion injury. Cell Death Differ. 18:10 (2011), 1651–1663.
88. [88] Zhang, C., Feng, Y., Qu, S., Wei, X., Zhu, H., Luo, Q., Liu, M., Chen, G., Xiao, X., Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53. Cardiovasc. Res. 90:3 (2011), 538–545.
89. [89] Wink, D.A., Hanbauer, I., Krishna, M.C., DeGraff, W., Gamson, J., Mitchell, J.B., Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc. Natl. Acad. Sci. 90:21 (1993), 9813–9817.
90. [90] Kim, Y.-M., Talanian, R.V., Billiar, T.R., Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J. Biol. Chem. 272:49 (1997), 31138–31148.
91. [91] Li, J., Billiar, T.R., Talanian, R.V., Kim, Y.M., Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem. Biophys. Res. Commun. 240:2 (1997), 419–424.
92. [92] Sbaa, E., Frérart, F., Feron, O., The double regulation of endothelial nitric oxide synthase by caveolae and caveolin: a paradox solved through the study of angiogenesis. Trends Cardiovasc. Med. 15:5 (2005), 157–162.
93. [93] Mineo, C., Shaul, P.W., Regulation of eNOS in Caveolae, Caveolins and Caveolae. 2012, Springer, 51–62.
94. [94] Gurha, P., Wang, T., Larimore, A.H., Sassi, Y., Abreu-Goodger, C., Ramirez, M.O., Reddy, A.K., Engelhardt, S., Taffet, G.E., Wehrens, X.H., microRNA-22 promotes heart failure through coordinate suppression of PPAR/ERR-nuclear hormone receptor transcription. PLoS One, 8(9), 2013, e75882.
95. [95] Hsu, C.-P., Zhai, P., Yamamoto, T., Maejima, Y., Matsushima, S., Hariharan, N., Shao, D., Takagi, H., Oka, S., Sadoshima, J., Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 122:21 (2010), 2170–2182.
96. [96] Yang, Y., Duan, W., Lin, Y., Yi, W., Liang, Z., Yan, J., Wang, N., Deng, C., Zhang, S., Li, Y., SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury. Free Radic. Biol. Med. 65 (2013), 667–679.
97. [97] Gerhart-Hines, Z., Rodgers, J.T., Bare, O., Lerin, C., Kim, S.H., Mostoslavsky, R., Alt, F.W., Wu, Z., Puigserver, P., Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGc-1α. EMBO J. 26:7 (2007), 1913–1923.
98. [98] Winnik, S., Auwerx, J., Sinclair, D.A., Matter, C.M., Protective effects of sirtuins in cardiovascular diseases: from bench to bedside. Eur. Heart J. 36:48 (2015), 3404–3412.
99. [99] Villena, J.A., New insights into PGC-1 coactivators: redefining their role in the regulation of mitochondrial function and beyond. FEBS J. 282:4 (2015), 647–672.
100. [100] Danz, E.D.B., Skramsted, J., Henry, N., Bennett, J.A., Keller, R.S., Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway. Free Radic. Biol. Med. 46:12 (2009), 1589–1597.
101. [101] Olmos, Y., Sánchez-Gómez, F.J., Wild, B., García-Quintans, N., Cabezudo, S., Lamas, S., Monsalve, M., SirT1 regulation of antioxidant genes is dependent on the formation of a FoxO3a/PGC-1α complex. Antioxid. Redox Signal. 19:13 (2013), 1507–1521.
102. [102] Alcendor, R.R., Gao, S., Zhai, P., Zablocki, D., Holle, E., Yu, X., Tian, B., Wagner, T., Vatner, S.F., Sadoshima, J., Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res. 100:10 (2007), 1512–1521.
103. [103] Qian, L., Van Laake, L.W., Huang, Y., Liu, S., Wendland, M.F., Srivastava, D., miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J. Exp. Med. 208:3 (2011), 549–560.
104. [104] Li, D., Tian, J., Guo, X., Huang, L., Xu, Y., Wang, C., Wang, J., Ren, A., Yuan, W., Lin, L., Induction of microRNA-24 by HIF-1 protects against ischemic injury in rat cardiomyocytes. Physiol. Res., 61(6), 2012, 555.
105. [105] Ye, Y., Hu, Z., Lin, Y., Zhang, C., Perez-Polo, J.R., Downregulation of microRNA-29 by antisense inhibitors and a PPAR-γ agonist protects against myocardial ischaemia–reperfusion injury. Cardiovasc. Res. 87:3 (2010), 535–544.
106. [106] Wang, L., Niu, X., Hu, J., Xing, H., Sun, M., Wang, J., Jian, Q., Yang, H., After myocardial ischemia-reperfusion, miR-29a, and let7 could affect apoptosis through regulating IGF. Biomed Res. Int., 2015, 2015, 1.
107. [107] Mott, J.L., Kobayashi, S., Bronk, S.F., Gores, G.J., mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26:42 (2007), 6133–6140.
108. [108] Park, S.-Y., Lee, J.H., Ha, M., Nam, J.-W., Kim, V.-N., miR-29 miRNAs activate p53 by targeting p85α and CDC42. Nat. Struct. Mol. Biol. 16:1 (2009), 23–29.
109. [109] Ye, Y., Lin, Y., Manickavasagam, S., Perez-Polo, J.R., Tieu, B.C., Birnbaum, Y., Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice. Am. J. Physiol. Heart Circ. Physiol. 295:6 (2008), H2436–H2446.
110. [110] Ye, Y., Lin, Y., Atar, S., Huang, M.-H., Perez-Polo, J.R., Uretsky, B.F., Birnbaum, Y., Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions. Am. J. Physiol. Heart Circ. Physiol. 291:3 (2006), H1158–H1169.
111. [111] Dorn, G.W., Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc. Res. 81:3 (2009), 465–473.
112. [112] Frey, N., McKinsey, T.A., Olson, E.N., Decoding calcium signals involved in cardiac growth and function. Nat. Med., 6(11), 2000.
113. [113] Aurora, A.B., Mahmoud, A.I., Luo, X., Johnson, B.A., van Rooij, E., Matsuzaki, S., Humphries, K.M., Hill, J.A., Bassel-Duby, R., Sadek, H.A., MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca 2+ overload and cell death. J. Clin. Invest. 122:4 (2012), 1222–1232.
114. [114] Bhuiyan, M., Takada, Y., Shioda, N., Moriguchi, S., Kasahara, J., Fukunaga, K., Cardioprotective effect of vanadyl sulfate on ischemia/reperfusion-induced injury in rat heart In vivo is mediated by activation of protein kinase B and induction of FLICE-Inhibitory protein. Cardiovasc. Drug Rev. 26:1 (2008), 10–23.
115. [115] Bhuiyan, M.S., Shibuya, M., Shioda, N., Moriguchi, S., Kasahara, J., Iwabuchi, Y., Fukunaga, K., Cytoprotective effect of bis (1-oxy-2-pyridinethiolato) oxovanadiun (IV) on myocardial ischemia/reperfusion injury elicits inhibition of Fas ligand and Bim expression and elevation of FLIP expression. Eur. J. Pharmacol. 571:2 (2007), 180–188.
116. [116] Pei-Yu, L., Yi, T., Shi-Yuan, X., Mediated protective effect of electroacupuncture pretreatment by miR-214 on myocardial ischemia/reperfusion injury. J. Geriatr. Cardiol., 11(4), 2014, 303.
117. [117] Gao, J., Zhang, L., Wang, Y., Lu, B., Cui, H., Fu, W., Wang, H., Yu, Y., Yu, X., Antiarrhythmic effect of acupuncture pretreatment in rats subjected to simulative global ischemia and reperfusion-involvement of adenylate cyclase, protein kinase A, and L-type Ca2+ channel. J. Physiol. Sci. 58:6 (2008), 389–396.
118. [118] Zhang, H., Liu, L., Huang, G., Zhou, L., Wu, W., Zhang, T., Huang, H., Protective effect of electroacupuncture at the Neiguan point in a rabbit model of myocardial ischemia-reperfusion injury. Can. J. Cardiol. 25:6 (2009), 359–363.
119. [119] Zhou, D., Li, H., Gao, Z., Influence of acupuncture and moxibustion pretreatment at Neiguan(PC 6) on Connexin 43 in myocardial cell in rabbits of myocardial ischemia reperfusion. Zhongguo Zhen Jiu 33:11 (2013), 1013–1016.
120. [120] Ren, X.-P., Wu, J., Wang, X., Sartor, M.A., Qian, J., Jones, K., Nicolaou, P., Pritchard, T.J., Fan, G.-C., MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 119:17 (2009), 2357–2366.
121. [121] De Celle, T., Vanrobaeys, F., Lijnen, P., Blankesteijn, W.M., Heeneman, S., Van Beeumen, J., Devreese, B., Smits, J.F., Janssen, B.J., Alterations in mouse cardiac proteome after in vivo myocardial infarction: permanent ischaemia versus ischaemia–reperfusion. Exp. Physiol. 90:4 (2005), 593–606.
122. [122] Fan, G.-C., Ren, X., Qian, J., Yuan, Q., Nicolaou, P., Wang, Y., Jones, W.K., Chu, G., Kranias, E.G., Novel cardioprotective role of a small heat-shock protein, Hsp20, against ischemia/reperfusion injury. Circulation 111:14 (2005), 1792–1799.
123. [123] Harada, M., Luo, X., Murohara, T., Yang, B., Dobrev, D., Nattel, S., MicroRNA regulation and cardiac calcium signaling role in cardiac disease and therapeutic potential. Circ. Res. 114:4 (2014), 689–705.
124. [124] Wang, X., Zhang, X., Ren, X.-P., Chen, J., Liu, H., Yang, J., Medvedovic, M., Hu, Z., Fan, G.-C., MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation 122:13 (2010), 1308–1318.
125. [125] Lorenzen, J.M., Batkai, S., Thum, T., Regulation of cardiac and renal ischemia-reperfusion injury by microRNAs. Free Radic. Biol. Med. 64 (2013), 78–84.
126. [126] van Rooij, E., Quiat, D., Johnson, B.A., Sutherland, L.B., Qi, X., Richardson, J.A., Kelm, R.J., Olson, E.N., A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev. Cell 17:5 (2009), 662–673.
127. [127] Wang, J.-X., Jiao, J.-Q., Li, Q., Long, B., Wang, K., Liu, J.-P., Li, Y.-R., Li, P.-F., miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat. Med. 17:1 (2011), 71–78.
128. [128] Dorn, G.W., Matkovich, S.J., Eschenbacher, W.H., Zhang, Y., A human 3′ miR-499 mutation alters cardiac mRNA targeting and function. Circ. Res. 110:7 (2012), 958–967.
129. [129] Youle, R.J., Karbowski, M., Mitochondrial fission in apoptosis. Nat. Rev. Mol. Cell Biol. 6:8 (2005), 657–663.
130. [130] De Rosa, S., Fichtlscherer, S., Lehmann, R., Assmus, B., Dimmeler, S., Zeiher, A.M., Transcoronary concentration gradients of circulating microRNAs. Circulation 124:18 (2011), 1936–1944.
131. [131] Li, J., Li, Y., Jiao, J., Wang, J., Li, Y., Qin, D., Li, P., Mitofusin 1 is negatively regulated by microRNA 140 in cardiomyocyte apoptosis. Mol. Cell. Biol. 34:10 (2014), 1788–1799.
132. [132] Gandre-Babbe, S., van der Bliek, A.M., The novel tail-anchored membrane protein Mff controls mitochondrial and peroxisomal fission in mammalian cells. Mol. Biol. Cell 19:6 (2008), 2402–2412.
133. [133] Long, B., Wang, K., Li, N., Murtaza, I., Xiao, J.-Y., Fan, Y.-Y., Liu, C.-Y., Li, W.-H., Cheng, Z., Li, P., miR-761 regulates the mitochondrial network by targeting mitochondrial fission factor. Free Radic. Biol. Med. 65 (2013), 371–379.
134. [134] Li, R., Yan, G., Li, Q., Sun, H., Hu, Y., Sun, J., Xu, B., MicroRNA-145 protects cardiomyocytes against hydrogen peroxide (H 2 O 2)-induced apoptosis through targeting the mitochondria apoptotic pathway. PLoS One, 7(9), 2012, e44907.
135. [135] Lomonosova, E., Chinnadurai, G., BH3-only proteins in apoptosis and beyond: an overview. Oncogene 27 (2008), S2–S19.
136. [136] Quinsay, M.N., Lee, Y., Rikka, S., Sayen, M.R., Molkentin, J.D., Gottlieb, R.A., Å. Gustafsson, B., Bnip3 mediates permeabilization of mitochondria and release of cytochrome c via a novel mechanism. J. Mol. Cell. Cardiol. 48:6 (2010), 1146–1156.
137. [137] Poliseno, L., Tuccoli, A., Mariani, L., Evangelista, M., Citti, L., Woods, K., Mercatanti, A., Hammond, S., Rainaldi, G., MicroRNAs modulate the angiogenic properties of HUVECs. Blood 108:9 (2006), 3068–3071.
138. [138] Suárez, Y., Fernández-Hernando, C., Pober, J.S., Sessa, W.C., Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ. Res. 100:8 (2007), 1164–1173.
139. [139] Cordes, K.R., Srivastava, D., MicroRNA regulation of cardiovascular development. Circ. Res. 104:6 (2009), 724–732.
140. [140] Barringhaus, K.G., Zamore, P.D., MicroRNAs regulating a change of heart. Circulation 119:16 (2009), 2217–2224.
141. [141] Latronico, M.V., Condorelli, G., MicroRNAs and cardiac pathology. Nat. Rev. Cardiol. 6:6 (2009), 418–429.
142. [142] Crow, M.T., Mani, K., Nam, Y.-J., Kitsis, R.N., The mitochondrial death pathway and cardiac myocyte apoptosis. Circ. Res. 95:10 (2004), 957–970.
143. [143] Ong, S.-B., Å. Gustafsson, B., New roles for mitochondria in cell death in the reperfused myocardium. Cardiovasc. Res. 94:2 (2011), 190–196.